المؤلفون: McAlpine RG; Clinical Psychopharmacology Unit, Clinical, Educational and Health Psychology, University College London, London, UK. rosalind.mcalpine.18@ucl.ac.uk., Sacchet MD; Meditation Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, USA., Simonsson O; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden., Khan M; Clinical Psychopharmacology Unit, Clinical, Educational and Health Psychology, University College London, London, UK., Krajnovic K; Clinical Psychopharmacology Unit, Clinical, Educational and Health Psychology, University College London, London, UK., Morometescu L; Clinical Psychopharmacology Unit, Clinical, Educational and Health Psychology, University College London, London, UK., Kamboj SK; Clinical Psychopharmacology Unit, Clinical, Educational and Health Psychology, University College London, London, UK.

المصدر: Scientific reports [Sci Rep] 2024 Feb 19; Vol. 14 (1), pp. 4072. Date of Electronic Publication: 2024 Feb 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Hallucinogens*/pharmacology, Pentamidine/*analogs & derivatives, Humans ; Psilocybin/pharmacology ; Mental Health ; Consciousness

المؤلفون: Lebedev AV; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. alexander.lebedev@ki.se.; Center for Cognitive and Computational Neuroscience, Karolinska Institutet, Stockholm, Sweden. alexander.lebedev@ki.se., Acar K; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Center for Cognitive and Computational Neuroscience, Karolinska Institutet, Stockholm, Sweden., Horntvedt O; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Cabrera AE; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Simonsson O; Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institute, Stockholm, Sweden., Osika W; Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institute, Stockholm, Sweden., Ingvar M; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Center for Cognitive and Computational Neuroscience, Karolinska Institutet, Stockholm, Sweden., Petrovic P; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Center for Cognitive and Computational Neuroscience, Karolinska Institutet, Stockholm, Sweden.

المصدر: Scientific reports [Sci Rep] 2023 Sep 30; Vol. 13 (1), pp. 16432. Date of Electronic Publication: 2023 Sep 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Hallucinogens*/adverse effects , Drug Users* , Substance-Related Disorders*/psychology, Humans ; Attitude ; Mental Health

المؤلفون: Simonsson O; Department of Sociology, University of Oxford, Oxford, UK. otto.simonsson@trinity.ox.ac.uk.; Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institute, Solna, Sweden. otto.simonsson@trinity.ox.ac.uk., Osika W; Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institute, Solna, Sweden.; Department of Neurobiology, Care Sciences and Society, Center for Social Sustainability, Karolinska Institute, Solna, Sweden.; Northern Stockholm Psychiatry, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden., Carhart-Harris R; Centre for Psychedelic Research, Imperial College London, London, UK., Hendricks PS; Department of Health Behavior, University of Alabama at Birmingham, Birmingham, UK.

المصدر: Scientific reports [Sci Rep] 2021 Jul 13; Vol. 11 (1), pp. 14427. Date of Electronic Publication: 2021 Jul 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Cardiovascular Diseases* , Hallucinogens* , Psilocybin*, Adult ; Humans